Clin2
NCT07693218Likely a fitActive, not recruiting

Study of BI 1815368 in healthy men

Healthy

Treatments studied

This trial tests how a new medicine, BI 1815368, is processed in the body of healthy men. The results will help researchers understand the drug's safety and how it works in the body.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
4 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are a healthy man between 18 and 55 years old.
  • Your body mass index (BMI) is between 18.5 and 29.9.
  • You have no significant medical conditions or abnormal lab results.
  • Your blood pressure and heart rate are within normal ranges.
  • You agree to sign a consent form and follow the study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07708493Not yet recruiting· Phase 1
Study of a new medicine in healthy men with normal or overweight

This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.

NCT07486115Recruiting· Phase 1
Testing safety of BI 3814916 in healthy volunteers

This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.

Edegem
NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT07774325Not yet recruiting· Phase 1
Study of BI 3002022 in healthy men

This study tests how a drug called BI 3002022 interacts with certain transport proteins in healthy men. It may help researchers understand how the drug is absorbed and eliminated by the body.

Biberach
NCT07486102Recruiting· Phase 1
Study of BI 3000202 in people with and without liver problems

This study tests how a new medicine, BI 3000202, is absorbed into the blood. It includes people with different levels of liver function (normal, mild, moderate, or severe) to see if liver problems affect how the medicine works.

San Antonio, Texas
NCT07023354Recruiting· Phase 1
Study of BI 1291583 in people with and without liver problems

This trial tests how a new medicine, BI 1291583, enters the blood in people who have different levels of liver function (from normal to mild, moderate, or severe liver problems). It helps doctors understand if the dose needs to be adjusted for liver health.

Rialto, California

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.